bpc 157 immunogenicity BPC-157 and the Difference Between an Evidence Gap and a Cover-Up: What the entire human evidence base actually looks like, and the questions to ask next. — WellFounded BPC-157 500mcg (60 capsules) –

As the systematic review noted: No clinical safety data were found. When the FDA says insufficient evidence, they mean itwe literally do not have the data to know whether chronic BPC-157 use causes problems that emerge years down the road

However, due to poor metabolic stability of angiotensin IV and many AnglV analogues, the inability of early analogues to penetrate the blood brain baixier, and the failure to identify the AT4 receptor, no pharmaceutical company has moved forward with their development

PMID 34170647

The PDGF-BBPDGFR pathway and its downstream signaling mechanisms regulate BBB maintenance by promoting pericyte survival, proliferation, migration, differentiation, adherence to the vascular wall, and leukocyte trafficking [42, 73]

Separate published data shows dramatic reductions in liver fat and significant improvements in insulin sensitivity